Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Dosanjh, Amrita ^a   Robison, Elizabeth ^a   Mondala, Tony ^a   Head, Steven R ^a   Salomon, Daniel R ^a   Kurian, Sunil M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Chronic Allograft Nephropathy Tubular atrophy with interstitial fibrosis (CAN IFTA); Chronic rejection; Genomics; Growth factors; Integrins; Kidney transplantation; Meta analysis; NA Microarrays; Proteomics

Indexed keywords

ALPHA6 INTEGRIN; BETA1 INTEGRIN; BETA5 INTEGRIN; BETA6 INTEGRIN; BETA8 INTEGRIN; CD51 ANTIGEN; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOINFORMATICS; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FUNCTIONAL PROTEOMICS; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY INJURY; MALE; MOLECULAR PATHOLOGY; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SIGNAL TRANSDUCTION; TUBULAR ATROPHY WITH INTERSTITIAL FIBROSIS;

ATROPHY; FIBROSIS; GRAFT REJECTION; HUMANS; INTEGRINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY TRANSPLANTATION; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84876731127     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-275     Document Type: Article

References (57)

1. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007, 7(3):518-526.
2. Mannon RB, Matas AJ, Grande J, Leduc R, Connett J, Kasiske B, Cecka JM, Gaston RS, Cosio F, Gourishankar S. Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant 10(9):2066-2073.
3. Mengel M, Reeve J, Bunnag S, Einecke G, Jhangri GS, Sis B, Famulski K, Guembes-Hidalgo L, Halloran PF. Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009, 9(8):1859-1867.
4. Park WD, Griffin MD, Cornell LD, Cosio FG, Stegall MD. Fibrosis with inflammation at one year predicts transplant functional decline. Journal of the American Society of Nephrology: JASN 2010, 21(11):1987-1997. 10.1681/ASN.2010010049, 3014013, 20813870.
5. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009, 9(10):2312-2323.
6. Jevnikar AM, Mannon RB. Late kidney allograft loss: what we know about it, and what we can do about it. Clin J Am Soc Nephrol 2008, 3(Suppl 2):S56-67. 3152273, 18309004.
7. Robertson H, Ali S, McDonnell BJ, Burt AD, Kirby JA. Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. Journal of the American Society of Nephrology: JASN 2004, 15(2):390-397. 10.1097/01.ASN.0000108521.39082.E1, 14747385.
8. Strutz F. Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction. Clin Transplant 2009, 23(Suppl 21):26-32.
9. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. Journal of the American Society of Nephrology: JASN 2005, 16(10):3015-3026. 10.1681/ASN.2005050463, 16120819.
10. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006, 81(5):643-654. 10.1097/01.tp.0000190423.82154.01, 16534463.
11. Sampson NS, Ryan ST, Enke DA, Cosgrove D, Koteliansky V, Gotwals P. Global gene expression analysis reveals a role for the alpha 1 integrin in renal pathogenesis. J Biol Chem 2001, 276(36):34182-34188. 10.1074/jbc.M102859200, 11447218.
12. Sharma K, Ziyadeh FN. The emerging role of transforming growth factor-beta in kidney diseases. Am J Physiol 1994, 266(6 Pt 2):F829-842.
13. Yates PJ, Nicholson ML. The aetiology and pathogenesis of chronic allograft nephropathy. Transpl Immunol 2006, 16(3-4):148-157.
14. Kong X, Mas V, Archer KJ. A non-parametric meta-analysis approach for combining independent microarray datasets: application using two microarray datasets pertaining to chronic allograft nephropathy. BMC Genomics 2008, 9:98. 10.1186/1471-2164-9-98, 2276496, 18302764.
15. Maluf DG, Mas VR, Archer KJ, Yanek K, Gibney EM, King AL, Cotterell A, Fisher RA, Posner MP. Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med 2008, 14(5-6):276-285. 2242778, 18286166.
16. Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, Mengel M, Reeve J, Sellares J, Sis B. The molecular phenotype of kidney transplants. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010, 10(10):2215-2222.
17. Park WD, Stegall MD. A meta-analysis of kidney microarray datasets: investigation of cytokine gene detection and correlation with rt-PCR and detection thresholds. BMC Genomics 2007, 8:88. 10.1186/1471-2164-8-88, 1852103, 17397532.
18. Saint-Mezard P, Berthier CC, Zhang H, Hertig A, Kaiser S, Schumacher M, Wieczorek G, Bigaud M, Kehren J, Rondeau E. Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection. Transplant international: official journal of the European Society for Organ Transplantation 2009, 22(3):293-302.
19. Rodder S, Scherer A, Raulf F, Berthier CC, Hertig A, Couzi L, Durrbach A, Rondeau E, Marti HP. Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009, 9(3):517-526.
20. Isse K, Lesniak A, Grama K, Roysam B, Minervini MI, Demetris AJ. Digital transplantation pathology: combining whole slide imaging, multiplex staining and automated image analysis. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012, 12(1):27-37.
21. Cordenonsi M, Montagner M, Adorno M, Zacchigna L, Martello G, Mamidi A, Soligo S, Dupont S, Piccolo S. Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation. Science 2007, 315(5813):840-843. 10.1126/science.1135961, 17234915.
22. Galliher AJ, Schiemann WP. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 2007, 67(8):3752-3758. 10.1158/0008-5472.CAN-06-3851, 17440088.
23. Kim ES, Kim MS, Moon A. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 2004, 25(5):1375-1382.
24. Botero TM, Son JS, Vodopyanov D, Hasegawa M, Shelburne CE, Nor JE. MAPK signaling is required for LPS-induced VEGF in pulp stem cells. J Dent Res 89(3):264-269.
25. Doanes AM, Hegland DD, Sethi R, Kovesdi I, Bruder JT, Finkel T. VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases. Biochem Biophys Res Commun 1999, 255(2):545-548. 10.1006/bbrc.1999.0227, 10049745.
26. Takahashi M, Matsui A, Inao M, Mochida S, Fujiwara K. ERK/MAPK-dependent PI3K/Akt phosphorylation through VEGFR-1 after VEGF stimulation in activated hepatic stellate cells. Hepatol Res 2003, 26(3):232-236. 10.1016/S1386-6346(03)00112-8, 12850696.
27. Choi YS, Cho HY, Hoyt KR, Naegele JR, Obrietan K. IGF-1 receptor-mediated ERK/MAPK signaling couples status epilepticus to progenitor cell proliferation in the subgranular layer of the dentate gyrus. GLIA 2008, 56(7):791-800. 10.1002/glia.20653, 18338791.
28. Awasthi V, King RJ. PKC, p42/p44 MAPK, and p38 MAPK are required for HGF-induced proliferation of H441 cells. Am J Physiol Lung Cell Mol Physiol 2000, 279(5):L942-949.
29. Liu ZX, Nickel CH, Cantley LG. HGF promotes adhesion of ATP-depleted renal tubular epithelial cells in a MAPK-dependent manner. Am J Physiol Renal Physiol 2001, 281(1):F62-70.
30. Wang M, Crisostomo PR, Herring C, Meldrum KK, Meldrum DR. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2006, 291(4):R880-884. 10.1152/ajpregu.00280.2006, 16728464.
31. Nakorchevsky A, Hewel JA, Kurian SM, Mondala TS, Campbell D, Head SR, Marsh CL, Yates JR, Salomon DR. Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J Am Soc Nephrol 21(2):362-373.
32. Grone HJ, Simon M, Grone EF. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 1995, 177(3):259-267. 10.1002/path.1711770308, 8551388.
33. Del Prete D, Ceol M, Anglani F, Vianello D, Tiralongo E, Valente M, Graziotto R, Bonfante L, Scaparrotta G, Furian L. Early activation of fibrogenesis in transplanted kidneys: a study on serial renal biopsies. Exp Mol Pathol 2009, 87(2):141-145. 10.1016/j.yexmp.2009.07.004, 19616542.
34. Baboolal K, Jones GA, Janezic A, Griffiths DR, Jurewicz WA. Molecular and structural consequences of early renal allograft injury. Kidney Int 2002, 61(2):686-696. 10.1046/j.1523-1755.2002.00149.x, 11849412.
35. Ishimura T, Ishida T, Fujisawa M. Significance of early biopsy in pediatric kidney transplantation. Aktuelle Urol 2003, 34(4):234-238.
36. Kushibiki T, Nagata-Nakajima N, Sugai M, Shimizu A, Tabata Y. Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis. J Control Release 2005, 105(3):318-331. 10.1016/j.jconrel.2005.02.030, 15936840.
37. Vargas GA, Hoeflich A, Jehle PM. Hepatocyte growth factor in renal failure: promise and reality. Kidney Int 2000, 57(4):1426-1436. 10.1046/j.1523-1755.2000.00987.x, 10760078.
38. Mizuno S, Matsumoto K, Nakamura T. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 2001, 59(4):1304-1314. 10.1046/j.1523-1755.2001.0590041304.x, 11260391.
39. Azuma H, Takahara S, Matsumoto K, Ichimaru N, Wang JD, Moriyama T, Waaga AM, Kitamura M, Otsuki Y, Okuyama A. Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. Journal of the American Society of Nephrology: JASN 2001, 12(6):1280-1292.
40. Thompson A, Bhandari V. Pulmonary Biomarkers of Bronchopulmonary Dysplasia. Biomark Insights 2008, 3:361-373. 2678850,2678850, 19430584.
41. Kerby JD, Luo KL, Ding Q, Tagouri Y, Herrera GA, Diethelm AG, Thompson JA. Immunolocalization of acidic fibroblast growth factor and receptors in the tubulointerstitial compartment of chronically rejected human renal allografts. Transplantation 1997, 63(7):988-995. 10.1097/00007890-199704150-00015, 9112353.
42. Flechner SM, Kurian SM, Solez K, Cook DJ, Burke JT, Rollin H, Hammond JA, Whisenant T, Lanigan CM, Head SR. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004, 4(11):1776-1785.
43. Tan HB, Feng Y, Liu M, Wu YC. Protective effects of FR167653 on chronic allograft nephropathy by inhibiting p38 MAPK in rats. Transplant Proc 2008, 40(5):1685-1689. 10.1016/j.transproceed.2008.01.073, 18589173.
44. Wada T, Azuma H, Furuichi K, Sakai N, Kitagawa K, Iwata Y, Matsushima K, Takahara S, Yokoyama H, Kaneko S. Reduction in chronic allograft nephropathy by inhibition of p38 mitogen-activated protein kinase. Am J Nephrol 2006, 26(4):319-325. 10.1159/000094365, 16816533.
45. Coito AJ, Korom S, Hancock WW, Kupiec-Weglinski JW. Blockade of alpha 4 beta 1-integrin-fibronectin adhesive interactions prevents chronic allograft rejection in sensitized recipients. Transplant Proc 1998, 30(4):939-940. 10.1016/S0041-1345(98)00099-2, 9636377.
46. Dosanjh A, Ikonen T, Morris R. Respiratory epithelial expression of integrin alphaVbeta6 in chronic progressive allograft rejection. J Heart Lung Transplant 2004, 23(4):456-460. 10.1016/S1053-2498(03)00206-7, 15063405.
47. Horan GS, Wood S, Ona V, Li DJ, Lukashev ME, Weinreb PH, Simon KJ, Hahm K, Allaire NE, Rinaldi NJ. Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am J Respir Crit Care Med 2008, 177(1):56-65. 10.1164/rccm.200706-805OC, 17916809.
48. Puthawala K, Hadjiangelis N, Jacoby SC, Bayongan E, Zhao Z, Yang Z, Devitt ML, Horan GS, Weinreb PH, Lukashev ME. Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med 2008, 177(1):82-90. 10.1164/rccm.200706-806OC, 2176115, 17916808.
49. Eskens FA, Dumez H, Hoekstra R, Perschl A, Brindley C, Bottcher S, Wynendaele W, Drevs J, Verweij J, van Oosterom AT. Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours. Eur J Cancer 2003, 39(7):917-926. 10.1016/S0959-8049(03)00057-1, 12706360.
50. Dudley JT, Chen R, Butte AJ. Matching cancer genomes to established cell lines for personalized oncology. Pac Symp Biocomput 2011, 16:243-252.
51. Morgan AA, Khatri P, Jones RH, Sarwal MM, Butte AJ. Comparison of multiplex meta analysis techniques for understanding the acute rejection of solid organ transplants. BMC Bioinforma 2010, 11(9):S6.
52. de Sousa AR, Penalva LO, Marcotte EM, Vogel C. Global signatures of protein and mRNA expression levels. Mol Biosyst 2009, 5(12):1512-1526.
53. Greenbaum D, Colangelo C, Williams K, Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003, 4(9):117. 10.1186/gb-2003-4-9-117, 193646, 12952525.
54. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. Global quantification of mammalian gene expression control. Nature 2011, 473(7347):337-342. 10.1038/nature10098, 21593866.
55. Vogel C, Abreu Rde S, Ko D, Le SY, Shapiro BA, Burns SC, Sandhu D, Boutz DR, Marcotte EM, Penalva LO. Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol Syst Biol 2010, 6:400. 2947365, 20739923.
56. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8(1):118-127. 10.1093/biostatistics/kxj037, 16632515.
57. de Jonge J, Kurian S, Shaked A, Reddy KR, Hancock W, Salomon DR, Olthoff KM. Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts. Am J Transplant 2009, 9(4):758-772. 10.1111/j.1600-6143.2009.02557.x, 2734955, 19353763.